1. Home
  2. ORKT vs SCLX Comparison

ORKT vs SCLX Comparison

Compare ORKT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
    SELLHOLDBUYas of 2024 years ago
  • SCLX
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • ORKT 2003
  • SCLX 2011
  • Country
  • ORKT Singapore
  • SCLX United States
  • Employees
  • ORKT N/A
  • SCLX N/A
  • Industry
  • ORKT
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • SCLX Health Care
  • Exchange
  • ORKT NYSE
  • SCLX Nasdaq
  • Market Cap
  • ORKT 82.9M
  • SCLX 81.7M
  • IPO Year
  • ORKT 2024
  • SCLX N/A
  • Fundamental
  • Price
  • ORKT $1.95
  • SCLX $0.45
  • Analyst Decision
  • ORKT
  • SCLX Strong Buy
  • Analyst Count
  • ORKT 0
  • SCLX 3
  • Target Price
  • ORKT N/A
  • SCLX $11.33
  • AVG Volume (30 Days)
  • ORKT 1.0M
  • SCLX 184.3K
  • Earning Date
  • ORKT 02-15-2025
  • SCLX 12-31-2024
  • Dividend Yield
  • ORKT N/A
  • SCLX N/A
  • EPS Growth
  • ORKT N/A
  • SCLX N/A
  • EPS
  • ORKT N/A
  • SCLX N/A
  • Revenue
  • ORKT $3,904,592.00
  • SCLX $50,833,000.00
  • Revenue This Year
  • ORKT N/A
  • SCLX $32.77
  • Revenue Next Year
  • ORKT N/A
  • SCLX $50.71
  • P/E Ratio
  • ORKT N/A
  • SCLX N/A
  • Revenue Growth
  • ORKT N/A
  • SCLX 9.41
  • 52 Week Low
  • ORKT $1.45
  • SCLX $0.43
  • 52 Week High
  • ORKT $8.00
  • SCLX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • SCLX 31.02
  • Support Level
  • ORKT N/A
  • SCLX $0.48
  • Resistance Level
  • ORKT N/A
  • SCLX $0.54
  • Average True Range (ATR)
  • ORKT 0.00
  • SCLX 0.05
  • MACD
  • ORKT 0.00
  • SCLX -0.01
  • Stochastic Oscillator
  • ORKT 0.00
  • SCLX 5.81

Stock Price Comparison Chart: ORKT vs SCLX

ORKT
SCLX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0246810121416ORKT VS SCLX

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use